Recent figures published by EMA relating to centralized procedure activities for human medicines appear to show a marked slowdown in the number of generic-drug applications filed and finalized this ...

PARSIPPANY, N.J. (AP) -- Generic drugmaker Actavis Inc. said Tuesday it has filed an application with federal regulators to market a generic version of the anti-inflammatory drug Rayos. Rayos is ...

Now that the Food and Drug Administration plans to fast-track generic drug applications in hopes of spurring competition and lowering medicines costs, a key question should be asked: Can the agency ...

The FDA signed off on a second generic option for the abortion pill mifepristone on Tuesday, hours before most of the federal government shut down and despite Republican opposition to the drug. Evita ...

Consumers and lawmakers pushing for cheaper alternatives to the EpiPen, an antidote for life-threatening allergic reactions, and other high-priced drugs are seeking answers about a stubborn backlog of ...

The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive ...

NAPLES, Fla. American consumers are waiting nearly a year longer for government regulators to approve new lower-priced generic drugs than they did in 2005. The delays, caused by a growing backlog of ...

The Bush administration on Thursday announced new rules that would hurry generic drugs to market by making it harder for the makers of brand-name versions to block the competition. The change, ...